The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- The Imperative of Intraoral Scanners in Contemporary Dental Practice: A Technical Exposition
- The Interwoven Realms of Dental and Mental Health: A Call for Comprehensive Care
- The Tale of Dr. Jahaan and Dr. Jiah: A Case Study in Dental Practice Decline
- Women in Dentistry: Redefining the Paradigm and Shaping the Future of Oral Healthcare
- Managing Post-SRP Dentinal Hypersensitivity: Evidence-Based Strategies for the Practicing Dentists
Archives